Yes, administer a loading dose of aspirin immediately
In patients presenting with acute coronary syndromes (ACS), you should give a loading dose of non-enteric-coated, chewable aspirin 162-325 mg as soon as possible after presentation, followed by a daily maintenance dose of 75-100 mg (81 mg preferred in the US). 1, 2, 3
Clinical Context and Dosing
The evidence is unequivocal across all major guidelines:
For NSTE-ACS (Non-ST-Elevation ACS):
- Loading dose: 162-325 mg non-enteric-coated, chewable aspirin immediately upon presentation 1
- Maintenance: 81 mg daily (preferred) or up to 325 mg daily 1
- The aspirin should be chewed when possible to achieve faster onset of antiplatelet action 3
For STEMI:
- Loading dose: 162-325 mg before primary PCI or with fibrinolytic therapy 2, 4
- Maintenance: 81-100 mg daily 2, 3
- Give the loading dose even if the patient is already on chronic aspirin therapy 3
For Acute Ischemic Stroke/TIA:
- Loading dose: 160-325 mg after intracranial hemorrhage is ruled out on neuroimaging 5
- Higher loading doses (160-325 mg) are associated with better functional outcomes compared to lower doses, though with increased minor bleeding risk 6
Key Evidence Supporting Loading Doses
The rationale for loading doses is robust: Research demonstrates that administering a loading dose of aspirin (200-500 mg) to patients already on chronic aspirin therapy results in sixfold lower thromboxane A2 synthesis compared to continuing 100 mg alone 7. This translates to:
- Marked reductions in platelet aggregation
- Only 8% poor responders with loading doses vs. 53% with maintenance doses alone 7
- Improved cardiovascular outcomes with good safety profile 8
Critical Implementation Details
Avoid enteric-coated aspirin initially because of delayed and reduced absorption 1. The non-enteric-coated formulation should be chewed for fastest onset.
For patients unable to take oral medication: Use rectal aspirin 325 mg daily or intravenous aspirin (where available) 5, 3
Important caveat on IV aspirin dosing: If using intravenous aspirin, avoid high doses (>300 mg). One retrospective study found that high-dose IV aspirin loading (mean 483 mg) was associated with significantly higher in-hospital mortality (9.3%) compared to low-dose IV (194 mg, 5.0% mortality) or oral aspirin (6.0% mortality) 9. This suggests that if IV administration is necessary, use lower doses (approximately 200 mg).
Contraindications to Consider
Before administering, verify the patient does not have 10:
- Known aspirin allergy or hypersensitivity
- Active major gastrointestinal bleeding
- Severe uncontrolled hypertension requiring emergency therapy
- Recent intracranial hemorrhage (for stroke patients, must rule out on imaging first)
Maintenance Therapy Considerations
After the loading dose, transition to low-dose aspirin (75-100 mg daily) for maintenance 3. High-dose maintenance aspirin (≥160 mg) increases bleeding risk without improving outcomes 1. When used with ticagrelor specifically, the maintenance dose must be 81 mg daily 1, 3.
The loading dose should be given even to patients already on chronic aspirin therapy - this is a Class I recommendation across all ACS guidelines and is supported by evidence showing improved platelet inhibition and reduced thromboxane-dependent reactivity 3, 8, 7.